Skip to content
Med Pharma News

Med Pharma News

Your Daily Dose of Pharma News

  • About Med Pharma News
  • Contact Us
  • News
  • Privacy Policy
  • Terms and Conditions
  • Home
  • Savara molgramostim FDA

Tag: Savara molgramostim FDA

Savara molgramostim FDA delay infographic for autoimmune pulmonary alveolar proteinosis
  • Pharmaceuticals

Savara Molgramostim FDA Decision Delayed: No New Date for First aPAP Drug

Megan Wood4 hours ago010 mins

The FDA will miss the 22 November goal date for Savara’s inhaled molgramostim in autoimmune PAP and has set no new date. What happened, the regulatory history and what analysts expect.

Read More

Categories

  • Healthcare IT (26)
  • Industry Insights (368)
  • Lifestyle and Wellness (24)
  • Medical Devices (45)
  • Pharmaceuticals (116)
  • Uncategorized (1)

Recent Posts

  • MAHA ELEVATE Model: CMS Awards $47M to 15 Groups to Test Lifestyle Medicine in Medicare
  • Rasonque EU Approval: Daraxonrasib Becomes Europe’s First RAS Pill for Pancreatic Cancer
  • Barzolvolimab Atopic Dermatitis Trial Fails: Celldex Drops Eczema to Focus on Hives
  • Savara Molgramostim FDA Decision Delayed: No New Date for First aPAP Drug
  • Xanamem Alzheimer’s Trial Misses Main Goal, Actinogen Shares Plunge Over 80%
Digital Newspaper - Multipurpose News WordPress Theme 2026. Powered By BlazeThemes.